Spectrum of pediatric neuromyelitis optica

Pediatrics

Volumn 122, Issue 5, 2008, Pages

  Lotze, Timothy E ^a,b   Northrop, Jennifer L ^b   Hutton, George J ^b   Ross, Benjamin ^b   Schiffman, Jade S ^c   Hunter, Jill V ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Central nervous system; Encephalomyelitis; Multiple sclerosis; Neuromyelitis optica; Spinal cord

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; GLUCOCORTICOID; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; APHASIA; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DISABILITY; DISEASE DURATION; FEMALE; HEMIPARESIS; HICCUP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; VOMITING; ATROPHY; BLOOD; BRAIN; CASE REPORT; IMMUNOLOGY; INFANT; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SPINAL CORD;

ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ATROPHY; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; INFANT; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; NEUROMYELITIS OPTICA; RECURRENCE; SENSITIVITY AND SPECIFICITY; SPINAL CORD;

EID: 58149144305     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2758     Document Type: Article

References (28)

1. Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters. " Arch Neurol. 2007;64(6):903-905
2. Galetta SL, Bennett J. Neuromyelitis optica is a variant of multiple sclerosis. Arch Neurol. 2007;64(6):901-903
3. Roach ES. Is neuromyelitis optica a distinct entity? Arch Neurol. 2007;64(6):906
4. Weinshenker BG. Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol. 2007;64(6):899-901
5. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805-815
6. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114
7. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112
8. Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007; 68(13)1076-1077
9. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F. Revised diagnostic criteria for neuromyelitis optica (NMO): application in a series of suspected patients. J Neurol. 2007; 254(9):1233-1237
10. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006;63(7):964-968
11. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(16 suppl 2):S7-S12
12. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-396
13. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489
14. Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007;68(16 suppl 2): S37-S45
15. Yang EB, Hood DC, Rodarte C, Zhang X, Odel JG, Behrens MM. Improvement in conduction velocity after optic neuritis measured with the multifocal VEP. Invest Ophthalmol Vis Sci. 2007;48(2):692-698
16. Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007;263(1-2):3-14
17. Poppe AY, Lapierre Y, Melancon D, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler. 2005;11(5): 617-621
18. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler. 2005;11(6):735-738
19. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology. 2005;65(9):1479-1482
20. Brinar VV, Poser CM, Basic S, Petelin Z. Sudden onset aphasic hemiplegia: an unusual manifestation of disseminated enceph-alomyelitis. Clin Neurol Neurosurg. 2004;106(3):187-196
21. Lacour A, De Seze J, Revenco E, et al. Acute aphasia in multiple sclerosis: a multicenter study of 22 patients. Neurology. 2004;62(6):974-977
22. Demeurisse G, Capon A, Verhas M, Attig E. Pathogenesis of aphasia in deep-seated lesions: likely role of cortical diaschisis. Eur Neurol. 1990;30(2):67-74
23. Vernant JC, Cabre P, Smadja D, et al. Recurrent optic neuro-myelitis with endocrinopathies: a new syndrome. Neurology. 1997;48(1):58-64
24. Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol. 1990;17(1):89-92
25. Manabe Y, Sasaki C, Warita H, et al. Sjogren's syndrome with acute transverse myelopathy as the initial manifestation. J Neurol Sci. 2000;176(2):158-161
26. Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am J Epidemiol. 2005;162(8):774-778
27. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology. 1988;38(6):990-991
28. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270-1272